HM20 Virtual
HM20 Virtual
HM20 Virtual product theaters: Aug. 25-27
Attendees of HM20 Virtual can start their day with informative Product Theaters presented by SHM’s valued partners.
HM20 Virtual
Welcome to the final week of HM20 Virtual!
Hospitalists, welcome to the final week of HM20 Virtual - the first virtual annual conference in the history of SHM.
HM20 Virtual
Performance status, molecular testing key to metastatic cancer prognosis
“The applicability of clinical trials data to hospitalized patients is generally poor. That’s an important caveat to keep in mind.”
HM20 Virtual
Hospitalists share work-parent experience during pandemic
Hospitalists described the strain that comes with the pandemic’s uncertainty and the mix of emotions they’ve experienced while working during a...
HM20 Virtual
Risk stratification key in acute pulmonary embolism
“I think if I had to pick the one thing that drives my decision the most about whether someone needs more aggressive therapy than anticoagulation...
HM20 Virtual
A ‘foolproof’ way to diagnose narrow complex tachycardias on EKGs
Ask these three questions about the EKG to quickly arrive at the right diagnosis.
HM20 Virtual
Cancer treatments bring concerns for hospitalists
With checkpoint inhibitors and CAR T-cell therapy, hospitalists need to act quickly to avoid problems that can affect nearly any organ in the body...
HM20 Virtual
Welcome to week 2 of HM20 Virtual!
HM20 Virtual has addressed one of the limitations of an online conference: personal interactions.
HM20 Virtual
COVID-19/heart connection: What hospitalists need to know
Be selective in ordering cardiac biomarker tests for COVID-19 patients, cardiologist advises.
HM20 Virtual
Developing COVID-19 hospital protocols during the pandemic
Hospitalists and other experts meet regularly to assess the literature and the dynamics of the pandemic in order to quickly pivot in the treatment...